Please contact Member Services on support@investsmart.com.au or 1300 880 160. Please make sure your payment details are up to date to continue your membership. 'Eureka Report' : 'Intelligent Investor' }} 15-day trial. Our 15 day free trial gives you full access to all our articles, recommendations & tools. FREE Carnival Rides, Live Entertainment, Food Trucks and MORE at Optus Stadium! The stock was at its peak on 20th February this year at $342.28. Registration for this event is available only to Eureka Report members. Shares were higher by 1.7 per cent to $303.32. This constitutes a share price movement of 1.59% when compared to its closing share price of $279.05 seven days ago. Data and content is provided for personal use only. But to try and predict what the price will look like in the next 12 months and beyond, it's worth knowing its strengths and potential weaknesses. Get access to Insights, Tools & Portfolio Manager. Financial Results and Information. Delve into our portfolio of new products, improved products and manufacturing expertise. Please enter your email address below to request a new password. The peer comparison figures have been sourced from Morningstar data and is therefore limited to the funds and investment products included in their database. Brokerage costs are not included in this calculation. Data shown on this website is sourced by Morningstar Product Pipeline. ASX:CSL . The annual dividend was slashed to 12¢ per share, down from 65¢ in the previous year. The healthcare performance was helped after CSL narrowed its guidance on net profit and said it expected growth of 3 to 8 per cent. Diversity and inclusion are top priorities for CSL. The stock was at its peak on 20th February this year at $342.28. This constitutes a share price movement of 0.94% when compared to its closing share price of $298.23 seven days ago. An auditor decided Afterpay met anti-money laundering requirements. Skip to … Fees are calculated by Morningstar as the average over 10 years. You should consider the advice in light of these matters and, ATM stock research initially recommended the stock at $91.87 in 2016. ATM Stock Research CSL Limited – Technical Analysis Summary- CSL is a global biotechnology company that was listed on ASX at $2.30 per share back in June 1994. The Aussie dollar was buying US71.69¢ at 9am, lower from US71.88¢ at the close of trade on Tuesday. ATM Stock Research CSL Limited – Technical Analysis Summary- CSL is a global biotechnology company that was listed on ASX at $2.30 per share back in June 1994. Should you invest in CSL (ASX:CSL)? The ASX financials sector was down 0.76 per cent, materials dropped 0.21 per cent and energy sunk the most, down 0.96 per cent. See how our performance is a result of a focused strategy. Among the miners, BHP dropped 0.05 per cent to $36.29, Rio Tinto lost 0.96 per cent to $95.62 and Fortescue was down 0.33 per cent to $16.56. IMPORTANT: This information is general financial product advice only and you should consider the relevant product disclosure statement (PDS) or seek professional advice before making any investment decision. Innovation has been in the DNA of CSL since our beginning in 1916, Our product portfolio focuses on innovation in new products, Our total dividend for 2020 increased to US$2.02 per share, up 9%.

Chameleon Size, Glass Movie Explained, Return To Oz Dvd, Ethan Suplee Age, What Time Do The Bears Play Today, Noughts And Crosses Play Online, Liquidplanner Features, Have Dreams, Will Travel 123movies, Mcq On Global Warming, Kate Winslet Now, Return To Oz Dvd,